Gilead Sciences's CEO Salary
- Daniel P. O’Day Chairman and Chief Executive Officer at Gilead Sciences, received a total compensation of $28.44 M in 2025.
- Dietmar Berger, M.D., Ph.D. Chief Medical Officer at Gilead Sciences, received a total compensation of $13.92 M in 2025.
- Johanna Mercier Chief Commercial and Corporate Affairs Officer at Gilead Sciences, received a total compensation of $9.30 M in 2025.
- Andrew D. Dickinson Chief Financial Officer at Gilead Sciences, received a total compensation of $8.77 M in 2025.
- Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel at Gilead Sciences, received a total compensation of $5.00 M in 2025.
Gilead Sciences's CEO salary and other executives compensation in 2025 was as follows:
Executive Compensation Summary Table
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Daniel P. O’Day Chairman and Chief Executive Officer | $28.44 M | $23.69 M | $22.61 M |
| Base Salary | $1.80 M | $1.77 M | $1.74 M |
| Incentive Plan Compensation | $4.85 M | $4.03 M | $4.04 M |
| All Other Compensation | $2.06 M | $1.34 M | $1.22 M |
| Stock Award | $15.24 M | $12.43 M | $11.87 M |
| Dietmar Berger, M.D., Ph.D. Chief Medical Officer | $13.92 M | - | - |
| Base Salary | $969.23 K | - | - |
| Incentive Plan Compensation | $1.60 M | - | - |
| All Other Compensation | $350.25 K | - | - |
| Stock Award | $7.00 M | - | - |
| Johanna Mercier Chief Commercial and Corporate Affairs Officer | $9.30 M | $8.61 M | $8.59 M |
| Base Salary | $1.18 M | $1.15 M | $1.11 M |
| Incentive Plan Compensation | $2.15 M | $1.85 M | $1.81 M |
| All Other Compensation | $102.98 K | $176.16 K | $176.58 K |
| Stock Award | $4.56 M | $4.14 M | $4.19 M |
| Andrew D. Dickinson Chief Financial Officer | $8.77 M | $8.11 M | $8.11 M |
| Base Salary | $1.12 M | $1.08 M | $1.05 M |
| Incentive Plan Compensation | $1.96 M | $1.61 M | $1.57 M |
| All Other Compensation | $70.98 K | $36.90 K | $37.89 K |
| Stock Award | $4.32 M | $4.08 M | $4.14 M |
| Deborah H. Telman Former Executive Vice President, Corporate Affairs and General Counsel | $5.00 M | $6.07 M | $5.27 M |
| Base Salary | $977.33 K | $967.72 K | $936.87 K |
| Incentive Plan Compensation | - | $1.44 M | $1.29 M |
| All Other Compensation | $55.48 K | $704.08 K | $337.17 K |
| Stock Award | $3.07 M | $2.15 M | $1.90 M |
| Johanna Mercier Chief Commercial Officer | - | $8.61 M | $8.59 M |
| Base Salary | - | $1.15 M | $1.11 M |
| Incentive Plan Compensation | - | $1.85 M | $1.81 M |
| All Other Compensation | - | $176.16 K | $176.58 K |
| Stock Award | - | $4.14 M | $4.19 M |
| Merdad V. Parsey, M.D., Ph.D. Chief Medical Officer | - | $8.11 M | $8.39 M |
| Base Salary | - | $1.14 M | $1.11 M |
| Incentive Plan Compensation | - | $1.41 M | $1.66 M |
| All Other Compensation | - | $27.48 K | $26.25 K |
| Stock Award | - | $4.21 M | $4.27 M |
| Deborah H. Telman Executive Vice President, Corporate Affairs and General Counsel | - | $6.07 M | $5.27 M |
| Base Salary | - | $967.72 K | $936.87 K |
| Incentive Plan Compensation | - | $1.44 M | $1.29 M |
| All Other Compensation | - | $704.08 K | $337.17 K |
| Stock Award | - | $2.15 M | $1.90 M |
